The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...

Bankrupt genetic testing company 23andMe has been sold to Regeneron Pharmaceuticals for $256 million. The deal includes ...

In an effort to become more nimble, some companies, like Bayer Pharmaceutical, are getting rid of middle managers.

The biopharma company said it filled the newly created role of chief operating officer to lead its commercial strategy, ...

Emcure Pharmaceuticals, Honasa Consumers, and Reliance Home Finance will be among 164 companies to post earnings reports for the January-March quarter on May 22 ...

Dr. Neema Bisht shared her inspiring journey from a practicing dentist to becoming a successful TEDx speaker, entrepreneur.

Analysts believe that recent product launches in India will further solidify Sun Pharmas leading position in the branded ...

Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug ...

Notably, the companys EBITDA surged by 16.5 percent, increasing from Rs 586.3 crore to Rs 683.2 crore from previous year.

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

Cumberland Pharmaceuticals' CEO discusses how potential tariffs on drugs could affect the Nashville-based company's business.

Apellis Pharmaceuticals focuses on creating medicines targeting eye diseases and rare neurological diseases. Read why I rate ...